BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20394971)

  • 1. Transurethral resection specimens of the bladder: outcome of invasive urothelial cancer involving muscle bundles indeterminate between muscularis mucosae and muscularis propria.
    Miyamoto H; Epstein JI
    Urology; 2010 Sep; 76(3):600-2. PubMed ID: 20394971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
    Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
    World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
    Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
    Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.
    Paner GP; Brown JG; Lapetino S; Nese N; Gupta R; Shen SS; Hansel DE; Amin MB
    Am J Surg Pathol; 2010 Jun; 34(6):792-9. PubMed ID: 20421781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.
    Hwang MJ; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Am J Clin Pathol; 2020 Jul; 154(2):208-214. PubMed ID: 32253420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
    Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer.
    Giunchi F; Panzacchi R; Capizzi E; Schiavina R; Brunocilla E; Martorana G; D'Errico A; Fiorentino M
    Clin Genitourin Cancer; 2016 Aug; 14(4):e307-12. PubMed ID: 26874973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
    Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
    Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
    May M; Bastian PJ; Burger M; Bolenz C; Trojan L; Herrmann E; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Otto W; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Wieland WF; Fritsche HM
    BJU Int; 2011 Oct; 108(8 Pt 2):E278-83. PubMed ID: 21699644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
    Mitra AP; Skinner EC; Miranda G; Daneshmand S
    BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-invasive urothelial carcinoma of the bladder.
    Malkowicz SB; van Poppel H; Mickisch G; Pansadoro V; Thüroff J; Soloway MS; Chang S; Benson M; Fukui I
    Urology; 2007 Jan; 69(1 Suppl):3-16. PubMed ID: 17280906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-staging (Beukers W; Meijer T; Vissers CJ; Boormans JL; Zwarthoff EC; van Leenders GJ
    Virchows Arch; 2012 Aug; 461(2):149-56. PubMed ID: 22777576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.